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ABSTRACT
Objective: To investigate the effects of allogenic adipose-derived stem cell (ADSC) transplantation on urethral tissue 
regeneration after vaginal distension in a rat model. Material & Method: 32 female wistar rats underwent vaginal 
distension (VD) for 4 h. Subsequently, PKH-labeled ADSCs (2 x 105 in 200 µl PBS, ADSC group, n = 18) or PBS (200 µl, 
placebo group, n = 18) were injected into periurethral tissue. Two and four weeks following transplantation (ADSC or 
PBS), voiding behavior (frequency) and muscle-collagen ratio of urethral tissue were measured to evaluate urethral 
sphincter regeneration. Data were analysed by paired-t test, one-way ANOVA and post hoc LSD. Results: Mean voiding 
frequency was significantly different in the ADSC group at two weeks (p < 0.0001), but not significantly different at four 
weeks (p = 0.448) when compared with the placebo group. Masson's trichrome staining revealed that the muscle-collagen 
ratio of urethral tissue was not significantly different between study groups at two or four weeks (p = 0.053 or p = 0.166 
respectively). Muscle-urethral ratio was more specific showing a significant difference at two weeks (p = 0.043). There were 
significant differences about muscle-collagen or muscle-urethral ratio between control and placebo groups (p < 0.05), 
whereas between control and ADSC groups no significant difference was observed (p > 0.05). Conclusion: ADSC 
transplantation promotes urethral muscle-collagen ratio with development of striated muscle after vaginal distension, so 
that can improve voiding behavior in a rat model.
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ABSTRAK
Tujuan: Membuktikan pengaruh pemberian stem cell mesenkimal jaringan lemak (ASDC/Adipose-Derived Stem Cell) 
terhadap proses regenerasi uretra pasca distensi vagina pada rattus norvegicus. Bahan & cara: Sebanyak 32 ekor tikus 
wistar betina menjalani prosedur distensi vagina dan sisanya 8 ekor sebagai kelompok kontrol tanpa perlakuan. Kelompok 
perlakuan mendapatkan injeksi ADSC atau plasebo periuretra. Pemeriksaan setelah hari ke-14 dan ke-28 meliputi 
perhitungan frekuensi miksi dan rasio tebal otot-kolagen jaringan uretra. Analisa data dengan menggunakan uji-t 
berpasangan, ANOVA dan post hoc LSD. Hasil: Rerata frekuensi miksi kelompok ADSC berbeda bermakna pada hari ke-
14 (p < 0.0001), namun tidak berbeda bermakna pada hari ke-28 (p = 0.448) bila dibandingkan dengan kelompok plasebo. 
Secara morfologi, rasio otot-kolagen tidak menunjukkan perbedaan yang bermakna antara kelompok ADSC dengan 
kelompok plasebo, baik pada hari ke-14 (p = 0.053) maupun hari ke-28 (p = 0.166), sedangkan rasio otot-uretra lebih 
spesifik dengan menunjukkan perbedaan yang bermakna pada hari ke-14 (p = 0.043). Namun apabila dibandingkan rasio 
otot-kolagen maupun rasio otot-uretra pada kelompok kontrol tanpa perlakuan, terdapat perbedaan yang bermakna 
dengan kelompok plasebo (p < 0.05), sedangkan dengan kelompok ADSC tidak berbeda bermakna (p > 0.05). Simpulan: 
Pemberian stem cell mesenkimal jaringan lemak meningkatkan pertumbuhan serat otot sirkuler (striated muscle) jaringan 
uretra yang sebelumnya mengalami kerusakan akibat distensi vagina, sehingga mampu memperbaiki fungsional miksi 
pada tikus wistar.
Kata kunci: Adipose-derived stem cell, distensi vagina, rat-SUI model, rasio otot-kolagen, voiding stain on paper.
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INTRODUCTION
Stress urinary incontinence (SUI) is defined 
as involuntary leakage or loss of urine during 
activities, such as exertion, coughing, sneezing or 
laughing, because of increase intra-abdominal 
pressure without contraction of detrusor muscle, is a 
common condition that can impact on health, social 
and economic problems which will ultimately affect 
1,2the quality of life.  Several epidemiological studies 
in Europe and the United States (1981-2000) were 
reviewed by Hunskaar et al revealed the overall 
prevalence of urinary incontinence in women ranged 
3from 10-40%.  The National Health and Nutrition 
Examination Survey (NHANES) between 2001-
2004 reported prevalence of any urinary 
incontinence among 4229 women over 20 years-old 
was 49.6%, with 49.8% suffering from SUI, 15.9% 
and 34.3% had urge and mixed urinary 
4incontinence.
Stress urinary incontinence in women 
occurs due to vesico-urethral hypermobility and/or 
intrinsic sphincter deficiency (ISD). Both of these 
mechanisms may occur during pregnancy or vaginal 
delivery in women with multiparity, delivery with 
vacuum or forceps, prolonged labor, or a large baby 
2(> 4000 g).  Hansen et al investigated prevalence of 
any incontinence during pregnancy and found 32.1% 
in primiparous women and 13.8% in nulliparous 
women. One year after vaginal delivery, prevalence 
was reported up to 29.3% in primiparous and 16.6% 
in nulliparous women. SUI is the most frequent type 
of urinary incontinence (during pregnancy were 
23.9% vs 7.3% and one year after delivery 15.8% vs 
8.3%, respectively in primiparous and nulliparous 
5women).
Currently, the therapeutic modalities for 
SUI still consists of non-surgical and surgical 
procedures. But side effects or complications often 
arise after surgical procedures, despite of intrinsic 
sphincter deficiency pathology that is commonly 
6-8found in patients with SUI still can't be corrected.  
In the last decade, a medical technology of tissue 
engineering has developed stem cell therapy for the 
management of SUI. Its use was first studied by 
Cannon et al in 2003 with periurethral allogenic stem 
cell transplantation in rat model that have been 
9,10manipulated to induce SUI.  Furthermore, several 
studies were applied to understand pathophysiology 
of SUI and stem cell therapy for the management of 
10-13SUI that were still limited in animal models,  but 
fewer have been studied also in humans who 
14,15suffered from SUI.
Particularly in Indonesia, studies of stem 
cell therapy in the urologic disorders are very rare. 
With these backgrounds, we studied in female wistar 
rat model suffering from SUI by vaginal distension 
procedure, to investigate the effect of allogenic 
adipose-derived stem cell (ADSC) transplantation 
on urethral tissue regeneration, both functionally and 
morphologically. 
OBJECTIVE
This research is aim to investigate the effects 
of allogenic adipose-derived stem cell (ADSC) 
transplantation on urethral tissue regeneration after 
vaginal distension in a rat model.
MATERIAL& METHOD
A total of 40 virgin female Wistar rats (rattus 
norvegicus, 8-12 weeks-old) weighing 150-250 
grams were randomized into three groups, A 
(control, n = 8), B (placebo, n = 16) and C (ADSC, n 
= 16). Study groups (B and C) were then divided into 
two sub-groups after stem cell or placebo injection, 
i.e. first group (B1, C1, n = 8) at two-weeks and 
second group (B2, C2, n = 8) at four-weeks 
examination, which consist of voiding frequency 
and urethral tissue histology. 
Thirty two rat models were anesthesized 
with a mixture of ketamine (80-100 mg/kg) and 
xylazine (5-10 mg/kg). To avoid rupturing the 
vagina, previously it was dilated using foley catheter 
from 8-Fr until 24-Fr size with lubrication. 
Subsequently a modified 10-Fr foley catheter was 
inserted into the vagina, the balloon was distended 
with water to 3 ml and the catheter was fixed with 
circumferential sutures around the urethral meatus. 
Catheter was retained in the vagina for 4 hours with a 
weight of 100 grams, with expected pressure and 
16,17ischemia on urethral wall.
Voiding frequency examination carried out 
by the method of VSOP (voiding stain on paper), 
using the filter paper placed ± 20 cm at the bottom of 
the cage and the rats were observed for 2 hours/day 
(among sunset time), 2-3 times observation periods 
for each rat models. Stress or sneeze manipulation 
was performed by sprinkling chili powder around the 
rat nostrils. Urine spots on the filter paper were 
viewed using ultraviolet light (fluorescence) and 
18,19voiding time and interval noted.  This procedure 
was performed before and third day after VD 
3procedure, afterwards at two-weeks and four-weeks 
after allogenic ADSC or placebo injection.
Fat tissue were isolated from the abdominal 
visceral fat, collected in a centrifuge tube and added 
0.2% collagenase solution at 37ºC for 60 minutes. 
Passage was performed several times (3–4 times) to 
isolate the stromal-vascular fraction. In the last 
rinsing, 8 ml pellet was resuspended on adipose stem 
cell medium (containing 5% fetal bovine serum, 2 
ng/ml basic fibroblast growth factor, 1% 
penicillin/streptomycin) and placed on a 100 mm x 
20 mm T-25 flask plate at 37ºC with 5% CO2 
(humidified incubator). Finally, several cells 
(adipose tissue-derived stromal vascular 
fraction/ADCVF) will adhere and grow for 2-4 days 
20before change of the medium.
After an midline abdominal incision, 
allogenic ADSCs were injected into both sides (3 and 
9, or 5 and 7 o'clock) of the periurethral tissue around 
the proximal urethra in a group C at 1 week after VD 
procedure. The ADSCs dosages were 200,000 cells 
in 200 mL of phosphate-buffered saline using 1 ml 
syringe. A group B only injected 200 mL of 
phosphate-buffered saline periurethral in the same 
place. All rat models were given prophylactic 
antibiotics (Procaine Penicilline 100 mg/kg 
13intramuscular) and analgesics.
Two-weeks (in first sub-group) and four-
weeks (in second sub-group) after injection of 
allogenic ADSC or placebo, 16 rats in each sub-
group were sacrificed by ether before surgery. Tissue 
material was isolated from the proximal urethra ± 1 
cm of length, fixed in 10% buffered formalin (pH 
7.4), embedded in paraffin blocks and sectioned into 
± 5 µm thick slices. Paraffin sections were stained 
with Masson's trichrome to distinguish the structure 
of muscle layer or rhabdo sphincter (red) and 
collagens (green or blue). Quantitative measure-
ments were made using graticule and then converted 
to micrometers in size (µm) using a computer 
software. 
The data were reported as means ± SD. Rat 
voiding frequency data were compared pre and post-
test in the same group and between study groups at 
the same time (14-days and 28-days). While muscle-
collagen and muscle-urethral ratio data were 
compared post-test only between group A (control), 
B (placebo) and C (ADSC) at the same time. The 
software SPSS 17.0 for windows was used for 
analysis with paired t-test and ANOVA, while the 
comparison between the study groups using a 
multivariate test and post hoc LSD test for a more 
specific assessment. A p value less than 0.05 was 
considered to be statistically significant. 
RESULTS
Voiding frequency examination was 
performed before and third day after VD procedure, 
followed at 14-days and 28-days after administration 
of placebo or periurethral ADSC. The results are 
reported as mean ± SD (see table 1, with 8 rat models 
were drop-out).
Table 2-5 revealed the same results, which a 
mean of voiding frequency were increased in the rat 
models after VD procedure compared before 
Table 1. The mean ± SD of voiding frequency.
Group n Pre VD Post VD 14-days 28-days 
Control 7 - - - - 
PBS 14-days 7 1.14 ± 0.378 2.29 ± 0.488 3.43 ± 0.976 - 
PBS 28-days 6 1.17 ± 0.408 2.50 ± 0.548 - 2.00 ± 0.894 
ADSC 14-days 6 1.00 ± 0.632 2.83 ± 0.752 1.67 ± 0.516 - 
ADSC 28-days 6 0.83 ± 0.753 3.33 ± 0.817 - 1.67 ± 0.516 
Table 2. Mean difference of voiding frequency in the 14-days placebo group (B1).
Pair Mean difference SD t value p  
Post VD - Pre VD 1.14 0.378 8.000 < 0.0001 
Day 14 - Pre VD 2.29 1.112 5.435 0.002 
Day 14 - Post VD 1.14 1.069 2.828 0.030 
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Table 3. Mean difference of voiding frequency in the 28-days placebo group (B2).
Pair Mean difference SD t value p  
Post VD - Pre VD 1.33 0.516 6.325 0.001 
Day 28 - Pre VD 0.83 1.169 1.746 0.141 
Day 28 - Post VD -0.50 1.049 -1.168 0.296 
Table 4. Mean difference of voiding frequency in the 14-days ADSC group (C1).
Pair Mean difference SD t value p  
Post VD - Pre VD 1.83 0.753 5.966 0.002 
Day 14 - Pre VD 0.67 0.516 3.162 0.025 
Day 14 - Post VD -1.17 0.983 -2.907 0.034 
Table 5. Mean difference of voiding frequency in the 28-days ADSC group (C2).
Pair Mean difference SD t value p  
Post VD - Pre VD 2.50 1.049 5.839 0.002 
Day 28 - Pre VD 0.83 0.408 5.000 0.004 
Day 28 - Post VD -1.67 0.817 -5.000 0.004 
Table 6. Mean difference of voiding frequency between study group.
The study group Mean difference Std. error Value of F p 
PBS D14 – ADSC D14 1.76 0.384 5.839 < 0.0001 













Figure 1. Cross-section of urethral tissue in rat models, Masson'strichrome staining, at 100x magnification with 
light microscope. Negative control group (above), placebo group at 14-days (middle-left), placebo 
group at 28-days (middle-right), ADSC group at 14-days (bottom-left), ADSC group at 28-days 
(bottom-right). SUE (external urethral sphincter), K (connective tissue collagen), L (urethral lumen). 
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procedure (p < 0.05). The voiding frequency was 
increased at 14th day after placebo administration 
(3.43 ± 0.976) compared with before (1.14 ± 0.378, p 
= 0.002) or after VD procedure (2.29 ± 0.488, p = 
0.030), whereas at 28th day after placebo 
administration showed no significant difference 
(tables 2 and 3). In the ADSC group, a mean of 
voiding frequency were reduced significantly at 14th 
day (1.67 ± 0.516) and 28th day (1.67 ± 0.516) after 
stem cell administration compared with voiding 
frequency after VD procedure (2.83 ± 0.752 and 3.33 
± 0.817 respectively, p < 0.05) (table 4 and 5). 
If the differences of voiding frequency in rat 
models were compared between study groups, 
significant differences seen in the group between the 
14th day after placebo administration compared with 
ADSC group (3.43 ± 0.976 vs 1.67 ± 0.516, p < 
0.0001), but at 28th day there is no significant 
difference (2.00 ± 0.894 vs 1.67 ± 0.516, placebo vs 
ADSC, p = 0.448) (table 6).
The muscle-collagen ratio is obtained by 
divided the measure of muscle and collagen 
thickness. Muscle-collagen ratio was highest in the 
untreated control group (0.75 ± 0.139), subsequently 
in the 28-days ADSC group (C2), 14-days ADSC 
group (C1), 28-days placebo group (B2) and lowest 
ratio in the 14-days placebo group (B1), respectively 
0,69 ± 0,209, 0.67 ± 0.111, 0.56 ± 0.183, and 0.50 ± 
0.135 (Fig. 2). The muscle-collagen ratio was 
significantly different only between the untreated 
control group compared with the placebo group, 
both of at 14-days and 28-days (p < 0.05). 
The muscle-urethral ratio is obtained by 
divided the measure of muscle and the urethra wall 
thickness. Muscle-urethral ratio was highest in the 
untreated control group (0.43 ± 0.046), and then 
followed in 28-days ADSC group (0.40 ± 0.070), 14-
days ADSC group (0.39 ± 0.042), 28-days placebo 
group (0.35 ± 0.073) and lowest ratio in the 14-days 
placebo group (0.33 ± 0.060) (Fig. 3). 
The muscle-urethral ratio was significantly 
difference between the untreated control group 
compared with the placebo group, both at 14-days 
and 28-days (p < 0.05), and between the 14-days 
placebo group compared with ADSC group (p < 
0.05). 
DISCUSSION
Stress urinary incontinence is very common 
in women during pregnancy and after vaginal 
delivery, especially related to large baby and 
Figure 2. Muscle-collagen ratio chart.  
Figure 3. Muscle-urethral ratio chart.
prolonged duration of the second stage of labor, 
caused by damage to the external urethral sphincter, 
the skeletal muscle as well as the smooth muscle of 
the urethra (intrinsic compartment), vaginal smooth 
muscle and other pelvic floor structures via direct 
compression or indirect hypoxia and ischemic 
mechanisms. Furthermore, this pathogenesis can be 
studied in animal models with vaginal distension 
procedure such as performed in this study. Several 
other studies about this method has proven effects of 
hypoxia and ischemia of the urethral tissue due to 
compression by balloon dilatation in the vagina 
(pressure-induced ischemia), causing damage of 
blood vessels or venous plexus in the submucosal 
layer, atrophy of the smooth muscle fibers and 
urethral striated muscle or rhabdo-sphincter in the 
muscular is layer and damage of the nerve cells of 
periurethral ganglia plexus. Ensuing weakness of 
external urethral sphincter and decrease of urethral 
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resistance, and leads stress urinary incontinence in 
17,21the animal model (animal-SUI model).
The results in this study showed that vaginal 
distension procedure can cause of symptoms similar 
with SUI in rat models. There is a significantly 
increased voiding frequency after VD in each study 
group compared to before VD. A significant increase 
of voiding frequency was also occurs at the 14th day 
after placebo administration, although at 28th days 
there wasn't significantly different. While in the 
ADSC group, transplantation of mesenchymal stem 
cells can be reduced of voiding frequency 
significantly at two-weeks and four-weeks when 
compared with the voiding frequency after VD 
procedure (or before the injection of stem cells).
The results of histologic examination 
showed that both of muscle-collagen ratio and 
muscle-urethral ratio in the placebo group were 
significantly lower when compared with the 
untreated control group, whereas in the ADSC group 
there was no significant difference compared with 
the control group. These results demonstrate that 
transplantation of stem cells capable to repairing and 
regenerating of muscle fibers in the muscularis layer 
of the urethra wall which previously damage due to 
vaginal distension. It is reinforced by the results of 
voiding frequency in the ADSC group were reduced 
significantly at the two-weeks until the four-weeks. 
Contrast, improvement was not observed in the 
placebo group, and reinforced by the results of 
voiding frequency after the second week of placebo 
administration was still increased significantly. 
ADSCs are multipotent cells which possess 
numerous advantages in myoblast inducement and 
autologous cell implantation. Adipose tissues are 
abundant, can easily be accepted by patients, and are 
obtained through a simple adipectomy. In addition, 
ADSCs are so abundant in the adipose tissues that 
only a minimal amount of adipose tissue is needed. 
ADSCs are also highly proliferative. Primary 
ADSCs can attach after 12 hours of isolation and 
quickly enter the log growth phase. ADSCs are 
homogenous and have uniform morphology, which 
help to prevent unpredictable side effects after 
implantation. Also, because they are highly 
proliferative and homogenous, ADSCs can easily be 
differentiated after induction. Finally, the quality of 
ADSCs is only minimally affected by age. Adipose 
tissues with abundant cells can readily be obtained, 
and can easily regenerate for multiple uses. ADSCs 
may be, therefore, more advantageously suitable in 
treating stress incontinence through the process of 
11homing and differentiation myoblasts.
Vaginal distension procedure in this study 
apparently causes acute and reversible urethral 
damage, according to the time and phases of wound 
healing  (inflamation, proliferation and remodeling). 
There was spontaneous healing at fourth week after 
VD procedure and placebo administration, voiding 
frequency was reduced at four-weeks in placebo 
group and muscle-collagen ratio were not 
significantly different between placebo and ADSC 
group, both of two and four-weeks. The other studies 
revealed similar results regarding the reversibility of 
vaginal distention effects due to compression for 
more than 1 hour (reperfusion injury), showing wide 
spread damage or disruption of striated muscle and 
thinning of the muscle fibers beginning on the fourth 
16,21,22 day, but gradually returned to normal 




Transplantation of allogenic adipose-
derivedstem cells (ADSC) promotes higher urethral 
muscle-collagen ratio with development of striated 
muscle after vaginal distension, which can improve 
the voiding behavior in a rat model.
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